Inhibition of TGF-β expression: A novel role for thiazolidinediones to implement renoprotection in diabetes

10Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Actual strategies to delay progression of diabetic nephropathy provide imperfect protection when started late in the course of the disease. Ohtomo et al. now demonstrate that thiazolidinedione treatment was associated with a remarkable improvement in proteinuria and renal function, offering a new potential treatment for diabetic nephropathy. © 2007 International Society of Nephrology.

Cite

CITATION STYLE

APA

Perico, N., & Remuzzi, G. (2007). Inhibition of TGF-β expression: A novel role for thiazolidinediones to implement renoprotection in diabetes. Kidney International. Nature Publishing Group. https://doi.org/10.1038/sj.ki.5002654

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free